POTS Lifestyle Management: Salt, Fluids, Compression

Waist-high, not knee-high alone, is what the evidence and patient guidance point to. POTS symptoms come partly from blood pooling in your legs on standing, but the abdominal and splanchnic veins pool blood too, a mechanism knee-high stockings simply do not reach. Dysautonomia International's own patient guidance names waist-high or at minimum thigh-high compression at 20 to 30 mmHg, paired with an abdominal binder for the abdominal pooling that leg compression alone leaves unaddressed. Knee-high compression is widely available and better than nothing, but on its own it is generally considered insufficient for POTS. This is expert-consensus and patient-organization guidance, not a large randomized trial.

That is a decision for your prescriber, not something to start on your own; here is what is actually known so you can have that conversation. Beta blockers are one of several medications used for POTS symptom control alongside midodrine, fludrocortisone and ivabradine. The best-known trial (Raj et al., Circulation 2009) found a low dose of propranolol reduced the standing heart-rate surge and improved symptoms, while a higher dose did not help more and looked worse; more is not automatically better. The 2015 Heart Rhythm Society expert consensus statement lists beta blockers among reasonable options, which is guideline recognition, not proof it will work for you specifically, and they are not right for everyone (asthma and some heart-conduction issues rule them out). Starting, choosing between, or adjusting any POTS medication is a physician decision based on your subtype and history.

In adults, POTS is defined by a sustained heart-rate increase of 30 beats per minute or more within about 10 minutes of standing (40 bpm or more in adolescents), without the blood-pressure drop that would point to orthostatic hypotension instead, plus symptoms on standing that ease when you lie back down. A tilt-table test is the formal diagnostic tool; a simpler in-office version, the NASA Lean Test, screens for it but is not a diagnosis on its own. If a doctor has dismissed your symptoms as 'just anxiety,' you are not alone, and it does not mean your symptoms are not real: Dysautonomia International states that POTS patients are not more likely, and by some measures less likely, to have an anxiety disorder than the general public. Bringing a written symptom log and asking specifically for a tilt-table test or NASA Lean Test screening, by name, is a concrete way to move that conversation forward.

It depends heavily on subtype and trigger. The best available prospective adult data (Kimpinski et al., Mayo Clinic Proceedings, 2012, n=58, one-year follow-up) found symptoms improved in most patients, and more than a third no longer met tilt-table criteria at one year, a relatively favorable prognosis for that cohort, which was not post-COVID and had mild autonomic dysfunction at baseline. Many adolescents improve over years with conventional treatment. For post-COVID POTS specifically, long-term prognosis is not yet well established; some people improve within a year, others do not, and we will not publish a percentage because none has been verified.

Heat is a real physiological trigger, not just discomfort. Hot skin dilates surface blood vessels to shed heat, and skin vessels can hold a large share of circulating blood; that pulls blood away from central circulation on top of the pooling already happening from standing, while sweating further shrinks blood volume. Hot showers combine heat, standing and a closed steamy space at once, which is why Dysautonomia International specifically advises lukewarm water, not hot or cold. For cooling itself, patient organizations recommend cooling vests, cold packs at the neck or wrists, a damp towel and a personal fan as comfort measures, but there is no dedicated clinical trial testing a cooling vest in POTS patients; treat one as a reasonable, low-risk comfort tool, not a proven treatment.